Asiatic Laboratories Statistics
Total Valuation
Asiatic Laboratories has a market cap or net worth of BDT 3.86 billion.
Market Cap | 3.86B |
Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, October 30, 2024.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Asiatic Laboratories has 122.39 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 122.39M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 55.71% |
Owned by Institutions (%) | 1.63% |
Float | 46.08M |
Valuation Ratios
The trailing PE ratio is 8.63.
PE Ratio | 8.63 |
Forward PE | n/a |
PS Ratio | 1.91 |
PB Ratio | 0.56 |
P/TBV Ratio | n/a |
P/FCF Ratio | 67.74 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.07.
Current Ratio | 2.73 |
Quick Ratio | 0.87 |
Debt / Equity | 0.07 |
Debt / EBITDA | 0.71 |
Debt / FCF | 6.46 |
Interest Coverage | 9.46 |
Financial Efficiency
Return on equity (ROE) is 8.25% and return on invested capital (ROIC) is 6.10%.
Return on Equity (ROE) | 8.25% |
Return on Assets (ROA) | 5.48% |
Return on Capital (ROIC) | 6.10% |
Revenue Per Employee | 1.88M |
Profits Per Employee | 416,265 |
Employee Count | 770 |
Asset Turnover | 0.31 |
Inventory Turnover | 2.73 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 33.68 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 43.64 |
Average Volume (20 Days) | 1,772,532 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Asiatic Laboratories had revenue of BDT 1.45 billion and earned 320.52 million in profits. Earnings per share was 3.65.
Revenue | 1.45B |
Gross Profit | 623.38M |
Operating Income | 415.51M |
Pretax Income | 371.48M |
Net Income | 320.52M |
EBITDA | 504.70M |
EBIT | 415.51M |
Earnings Per Share (EPS) | 3.65 |
Balance Sheet
The company has 8.98 million in cash and 367.80 million in debt, giving a net cash position of -358.81 million or -2.93 per share.
Cash & Cash Equivalents | 8.98M |
Total Debt | 367.80M |
Net Cash | -358.81M |
Net Cash Per Share | -2.93 |
Equity (Book Value) | 4.97B |
Book Value Per Share | 56.61 |
Working Capital | 399.53M |
Cash Flow
In the last 12 months, operating cash flow was 432.01 million and capital expenditures -375.10 million, giving a free cash flow of 56.91 million.
Operating Cash Flow | 432.01M |
Capital Expenditures | -375.10M |
Free Cash Flow | 56.91M |
FCF Per Share | 0.46 |
Margins
Gross margin is 42.95%, with operating and profit margins of 28.63% and 22.09%.
Gross Margin | 42.95% |
Operating Margin | 28.63% |
Pretax Margin | 25.60% |
Profit Margin | 22.09% |
EBITDA Margin | 34.78% |
EBIT Margin | 28.63% |
FCF Margin | 3.92% |
Dividends & Yields
Asiatic Laboratories does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 11.58% |
FCF Yield | 1.48% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Asiatic Laboratories has an Altman Z-Score of 1.1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.1 |
Piotroski F-Score | n/a |